Clinical Trial Update: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating Ivaltinostat with Capecitabine (or Capecitabine alone) for metastatic pancreatic adenocarcinoma; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Ivaltinostat

Snippet

Sponsor: CG Pharmaceuticals, Inc | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING